Dihydrophenanthrene

Dihydrophenanthrene

SCHEMBL155991

c1ccc2c(c1)CCc1ccccc1-2

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 1/20 0.68
MAOA P21397 2/20 0.52
MAOB P27338 2/20 0.52
CYP2A6 P11509 1/20 0.52
SRD5A1 P18405 1/20 0.52
SRD5A2 P31213 1/20 0.52
TSHR P16473 1/20 0.50
SETD7 Q8WTS6 1/20 0.50
NOS3 P29474 1/20 0.48
NOS2 P35228 1/20 0.48
PDPK1 O15530 1/20 0.48
PARP1 P09874 1/20 0.48
PARP10 Q53GL7 1/20 0.48
PARP11 Q9NR21 1/20 0.48
L3MBTL1 Q9Y468 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
HPGD P15428 1/20 0.46
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
CYP19A1 P11511 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dihydrophenanthrene SCHEMBL30297028 1.00 CES1 (0.68) CES1MAOAMAOBCYP2A6SRD5A1
Dihydrophenanthrene SCHEMBL29404495 1.00 CES1 (0.68) CES1MAOAMAOBCYP2A6SRD5A1
Dihydrophenanthrene SCHEMBL28858771 0.97 CES1 (0.65) CES1MAOAMAOBCYP2A6SRD5A1
SCHEMBL30436624 0.97 CES1 (0.65) CES1MAOAMAOBCYP2A6SRD5A1
Dihydrophenanthrene SCHEMBL28876918 0.97 CES1 (0.65) CES1MAOAMAOBCYP2A6SRD5A1
SCHEMBL4818156 0.88 CES1 (0.56) CES1MAOAMAOBCYP2A6SRD5A1
Dihydrophenanthrene SCHEMBL29057227 0.88 CES1 (0.56) CES1MAOAMAOBCYP2A6SRD5A1
Dihydrophenanthrene SCHEMBL30082507 0.88 CES1 (0.56) CES1MAOAMAOBCYP2A6SRD5A1
SCHEMBL31430380 0.87 TSHR (0.71) CES1MAOAMAOBCYP2A6SRD5A1
SCHEMBL568779 0.87 TSHR (0.71) CES1MAOAMAOBCYP2A6SRD5A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1987 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4608895-A1 HIGH TEMPERATURE DIELECTRIC POLYMERS AND FILMS The Scripps Research Institute (US) 2025-09-03 EP claimed
CN-119161290-A Chiral imide carboxylic acid double rhodium complex and preparation method and application thereof 兰州大学 2024-12-20 CN claimed
EP-4321602-B1 SULFUR FREE POLY ALKYL(METH)ACRYLATE COPOLYMERS AS VISCOSITY INDEX IMPROVERS IN LUBRICANTS EVONIK OPERATIONS GMBH (DE) 2024-09-11 EP claimed
CN-116023995-B Method for producing low-sulfur petroleum coke 中国石油化工股份有限公司 2024-07-09 CN claimed
US-11999819-B2 Formulation containing a highly branched polymer, highly branched polymer and electro-optical device containing this highly branched polymer MERCK PATENT GMBH (DE) 2024-06-04 US claimed
US-11981613-B2 Hydrogen isotope exchange methods and systems for organic and organosilicon materials BATTELLE SAVANNAH RIVER ALLIANCE, LLC (US) 2024-05-14 US claimed
WO-2024091675-A1 HIGH TEMPERATURE DIELECTRIC POLYMERS AND FILMS THE SCRIPPS RESEARCH INSTITUTE (US) 2024-05-02 WO claimed
WO-2024091684-A1 POLYSULFATE AND POLYSULFONATE POLYMERS THE SCRIPPS RESEARCH INSTITUTE (US) 2024-05-02 WO claimed
EP-4334395-A1 UV-ABSORBING POLYMERS, COMPOSITIONS AND USES THEREOF Beckman Coulter, Inc. (US) 2024-03-13 EP claimed
CN-111440633-B Mesophase pitch and preparation method and application thereof 湖南东映长联科技有限公司 2024-03-01 CN claimed
US-4728796-A Method for ionization of polymers MEDICAL COLLEGE OF WISCONSIN (US) 1988-03-01 US claimed
WO-1987006254-A1 INTEGRATED IONIC LIQUEFACTION PROCESS CARBON RESOURCES, INC. (US) 1987-10-22 WO claimed
US-4695405-A Process for quenching fluorescence, and new cationic or amphoteric aromatic nitro compounds BAYER AKTIENGESELLSCHAFT (DE) 1987-09-22 US claimed
US-4596652-A Process for producing mesophase pitch MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1986-06-24 US claimed
EP-0163854-A2 Process for the elimination of fluorescence and cationic or amphoteric aromatic nitro compounds BAYER AG (DE) 1985-12-11 EP claimed
EP-0121343-A1 Integrated ionic liquefaction process PENTANYL TECHNOLOGIES, INC. (US) 1984-10-10 EP claimed
US-4476009-A Process for improving the hydrogen donor properties of a coal liquefaction solvent TEXACO INC. (US) 1984-10-09 US claimed
US-4451351-A SOLVENT SYSTEM OF PHENOLS AND ALKALI OR ALKALINE EARTH METAL COMPOUNDS PENTANYL TECHNOLOGIES, INC. (US) 1984-05-29 US claimed
US-4096154-A FORMING A SULFONIUM SALT BY REACTION OF A HALOGEN AS ESTER WITH AN ORGANIC SULFIDE CIBA-GEIGY CORPORATION (US) 1978-06-20 US claimed
US-4016203-A Process for the manufacture of compounds containing vinyl groups CIBA-GEIGY CORPORATION (US) 1977-04-05 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11981613-B2 Hydrogen isotope exchange methods and systems for organic and organosilicon materials HNMT, DOHH, HDHD5 CES1 3461/4885MAOA 864/4885MAOB 854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.